Table 1.
Baseline patient characteristics
| Baseline characteristics | Overall (n = 35) |
|---|---|
| Gender, n (%) | |
| Female | 14 (40) |
| Male | 21 (60) |
| Median age, years (range) | 53 (27–79) |
| >60 (%) | 22 (63) |
| <60 (%) | 13 (37) |
| ECOG PS, n (%) | |
| 0 | 8 (23) |
| 1 | 27 (77) |
| Race, n (%) | |
| White | 31 (89) |
| African American | 2 (6) |
| Hispanic | 1 (3) |
| Asian | 1 (3) |
| Tumor types, n (%) | |
| GEA | 10 (29) |
| CRC | 20 (58) |
| HCC | 5 (14) |
| Prior lines of therapy | |
| Median | 2 |
| 0 | 4 (11) |
| 1 | 7 (20) |
| 2 | 11 (31) |
| 3 | 13 (37) |
| MMR status, n (%) | |
| MMR proficient | 35 (100) |
| Patients with liver metastasis, n (%) | |
| GEA | 4 (40) |
| CRC | 15 (75) |